Sino-U.S. healthcare investment firm Vivo Capital has reached final closing of its eighth fund, Vivo Capital Fund VIII L.P., at US$750 million, according to a company announcement. With offices in Palo Alto, California, as well as in Beijing and Shanghai in China, Vivo Capital says the latest closing will bring the firm's total assets-under-management to […]

Visit for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.

Visit the original source and full text: China Money Network